Skip to main content
Caplight Logo









Lembas

Lembas

Private
Tel AvivHealthcare & Life Scienceshttps://www.hellolembas.com/

Last Round

Pre Seed

Jun 11, 2025

Total Funding Raised

$3.6M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Lembas is a biotechnology company that has developed an AI-powered discovery platform to create bioactive ingredients for functional foods and supplements, with a first product aimed at appetite regulation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

bioactive peptidesGLP-1functional foodweight managementmetabolic healthfood techAI drug discoverynatural supplementsappetite regulationingredient supplierozempic alternativecomputational biologypeptide designB2B ingredients

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lembas Comparables

Compare Lembas with similar companies based on industry and business-model similarity.

Lembas comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nuritas
75%
Zero Cow Factory
71%
Brightseed
66%

Lembas Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJun 11, 2025

Key People

Founding team and executive leadership

Zohar Barbash

CTO And Co-founder

Founding Team

Shay Hilel

CEO Co-Founder

Founding Team

Lembas Investors

Notable investors and investment history

Lembas investors
InvestorRounds
Fresh.FundPre Seed
FLORA VenturesPre Seed
SDH VenturesPre Seed
Maia VenturesPre Seed
Longevity Venture PartnersPre Seed
Bluestein VenturesPre Seed
Mandi VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 943% MoM, reaching 2.1K.

  • May 19, 2026

    Monthly visitors increased 1545% MoM, reaching 2.4K.

Lembas Filings

Explore SEC and related filing metadata, where available.

Lembas filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lembas's valuation, stock price, and market status.

Is Lembas a public or private company?

Lembas is a private company.

What is the current stock price of Lembas?

Lembas is a private company with no public stock price. No recent secondary market data is available.

How much is Lembas worth (valuation)?

Valuation information for Lembas is not publicly available.

Can I buy Lembas stock?

Lembas shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lembas's last funding round?

Lembas's most recent funding round was Pre Seed on June 11, 2025.

Who are the main investors in Lembas?

Key investors in Lembas include FLORA Ventures.

Will Lembas IPO soon?

No public IPO plans have been announced for Lembas.

How can I track Lembas secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lembas's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTel Aviv
Employee Range10
Year Founded2024
Last FundingJun 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?